Target intelligence / Profile preview

Picornavirus VP1 coat protein (VP1)

Target
VP1
Molecular classification
Structural protein, Viral capsid protein, Other (virus component)
01

Overview

The Picornavirus VP1 coat protein is a major structural protein forming part of the icosahedral capsid of all picornaviruses. Sixty copies of VP1, together with VP2, VP3, and (internally) VP4, assemble to protect the viral RNA genome. VP1 localizes predominantly at the five-fold axes of the viral particle and is crucial in forming the "canyon," a depression on the capsid surface that in many picornaviruses serves as the receptor-binding site. During viral entry, VP1 undergoes conformational changes, partially extruding from the capsid to help mediate attachment and penetration of the host cell membrane, ultimately enabling genome release into the cytoplasm. The “jelly-roll” eight-stranded beta-barrel structure of VP1 is highly conserved, but its surface loops are variable, allowing for antigenic diversity and playing a central role in host immune evasion. The VP1 pocket is a binding site for small-molecule antivirals, such as pleconaril, that block viral uncoating. As a principal antigenic determinant, VP1 is both a target for neutralizing antibodies and immune decoy particles and is commonly used for serological detection of multiple picornavirus infections.

Other names
VP1Viral protein 1Capsid protein VP1
02

Mechanism of action

Inhibition of uncoating and viral entry by stabilizing the capsid (pleconaril and similar drugs bind to a hydrophobic pocket within VP1, preventing capsid rearrangements required for genome release)

03

Biological functions

Viral capsid formationViral genome protectionHost cell entryImmune evasion/antigenic variation
04

Disease associations

Infection (role in a wide range of diseases caused by picornaviruses, including poliomyelitis, hand-foot-and-mouth disease, viral myocarditis, and the common cold)
05

Safety considerations

High antigenic variation in VP1 may result in immune escape and limits vaccine and therapeutic efficacyResistance mutations can emerge against capsid-binding drugs
06

Interacting drugs

Pleconaril (capsid-binding inhibitor)

1 more in the full profile.

07

Biomarkers

Presence of anti-VP1 antibodies as markers of infection or immune response (used in diagnostic assays for several picornavirus infections)

Beyond the preview

Go deeper on Picornavirus VP1 coat protein (VP1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Picornavirus VP1 coat protein (VP1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call